John L. Flavin named Executive Chairman

CHICAGO – AltaThera Pharmaceuticals, a commercial-stage specialty pharmaceutical company, has announced the appointment of John L. Flavin as Executive Chairman.

John L. Flavin

Flavin, a seasoned pharmaceutical executive with a track record of building new businesses and delivering sustainable growth, has more than 20 years of experience in the management, operations and financing of both public and private biomedical companies. He has led two successful NASDAQ IPOs and raised more than $220 million in public and private funding.

At AltaThera, Flavin joins a management team with nearly 100 years combined experience in the evaluation, development, financing and marketing of specialty pharmaceutical products.

AltaThera President and CEO Brandon Kashfian says Flavin brings a depth of operating and financial experience that will enhance AltaThera’s near- and long-term objectives.

“Our partnership with John will significantly advance the Company’s mission of providing critical care and alternative therapeutics for unmet medical needs,” Kashfian said.

Flavin says AltaThera’s focus on maximizing the value of under-managed specialty products using its market research-driven business model, along with its partnerships with patient advocacy organizations, will expand access to life-saving treatments for small, often underserved patient populations in the U.S.

“I look forward to working with AltaThera’s management team to advance the Company’s product portfolio and build a world-class organization,” he said.

Flavin also serves as Managing Director of Flavin Ventures, a life sciences venture and management firm, and is a frequent lecturer at the University of Chicago Booth Graduate School of Business, where he speaks on biotechnology entrepreneurship. In addition, he serves as Executive Director of Chicago Innovation Mentors, a multi-institution consortium focused on commercializing university research.  Flavin is a member of the life sciences diligence panel for the Invest Illinois Venture Fund and served as Co-Chair of the BIO 2013 International Convention Program Committee.

About AltaThera: AltaThera Pharmaceuticals is a specialty pharmaceutical company focused on critical care and alternative therapeutics for the unmet medical needs of patients with severe, and often rare, disorders for which few effective treatments are available.

Patricia Dunnigan
Manager, Communications & Marketing
AltaThera Pharmaceuticals
200 S. Wacker Drive
Suite 3100
Chicago, IL 60606
[email protected]

© 2016 ALTATHERA Pharmaceuticals. All rights reserved.

CA Compliance | Privacy Policy | Terms of Use | Site Map